European Archives - Page 289 of 1317 - European Medical Journal

Maintaining Healthy Weight Reduces Risk of Multiple Myeloma

A recent study found that patients with monoclonal gammopathy of undetermined significance who maintain a healthy weight have a lower risk of progression to multiple myeloma.

SAPIEN 3 Ultra RESILIA valve: 1-year real-world outcomes with significant mortality benefits for patients

SAPIEN 3 Ultra RESILIA valve shows significant 1-year benefits, including lower all-cause mortality (driven by lower PVL), stroke, and…

Benefit of Dual Immunotherapy in GI Cancers

This infographic summarises three ongoing studies that demonstrate the benefit of dual immunotherapy combination therapy compared…

Revolutionising Interventional Cardiology and Mental Health Through the Lens of Aviation

In this episode Jonathan welcomes William Lombardi, one of the leading innovators in chronic total occlusion percutaneous coronary intervention.

The Link Between Dietary Fats and Type 2 Diabetes Risk

Plant-based monounsaturated fats may lower Type 2 diabetes risk, while animal-derived sources are linked to higher risk.

Camel Milk Shows Promise as a Less Allergenic Dairy Alternative

Fractionation techniques can significantly enhance the identification of bioactive peptides and immune-related proteins in camel and cow milk.

Britain

ABPI reveals data on UK’s life sciences competitive edge

A new survey from the ABPI has revealed a surge in apprenticeships, placements and global research collaborations in the UK pharma space.

Antihistamines Offer New Hope in Erythropoietic Protoporphyria

This study revealed an association between elevated hepatic histamine levels, mast cell infiltration, and erythropoietic protoporphyria progression.

New AI Model Detects Early Signs of Parkinson’s with High Accuracy

A deep-learning algorithm predicts Parkinson’s disease using medical claims and prescriptions, improving early detection and clinical screening.

5 minutes with... Jaime Manzanera, Eisai

Jaime Manzanera, EMEA Brand Director, Oncology, Eisai, shares his perspective on maximising ROI in pharmaceutical marketing and more.